Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer? - Takeaways - MDSpire

Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer?

A Keck Medicine of USC head and neck surgeon discusses circulating HPV DNA as a biomarker that could help make more individualized treatment decisions.

  • By

  • March 24, 2026

  • 5 min

Share

  • 1

    Circulating HPV DNA (HPV ctDNA) is being investigated as a potential biomarker for predicting HPV-related throat cancer.

  • 2

    Initial studies indicate that HPV ctDNA levels in blood correlate with disease burden, aiding in treatment response assessment.

  • 3

    HPV ctDNA testing could provide a minimally invasive method to monitor cancer presence before, during, and after treatment.

  • 4

    More research is needed to validate HPV ctDNA as a reliable biomarker and to establish standardized testing methods.

  • 5

    The integration of HPV ctDNA tests may enhance personalized treatment plans, reducing unnecessary therapies and toxicities.

Original Source(s)

Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer?

  • by

  • March 24, 2026

Related Content

Case Report: Primary sciatic leiomyosarcoma in a patient with neurofibromatosis type 1

Deep-Motion-Net: GNN-based volumetric liver shape reconstruction from single-view 2D projections

JAMA Dermatology —The Year in Review, 2025